Vontobel Holding Ltd. Has $1.05 Million Stock Holdings in Humana Inc. (NYSE:HUM)

Vontobel Holding Ltd. lowered its position in Humana Inc. (NYSE:HUM - Free Report) by 26.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,971 shares of the insurance provider's stock after selling 1,394 shares during the quarter. Vontobel Holding Ltd.'s holdings in Humana were worth $1,051,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Dodge & Cox boosted its stake in Humana by 106.7% during the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock valued at $2,587,345,000 after purchasing an additional 5,264,045 shares during the period. Vanguard Group Inc. increased its holdings in shares of Humana by 15.8% during the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after purchasing an additional 1,751,857 shares during the period. Norges Bank bought a new stake in shares of Humana in the fourth quarter valued at about $416,202,000. Pzena Investment Management LLC increased its stake in Humana by 44.0% during the fourth quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after acquiring an additional 1,103,132 shares during the period. Finally, Boston Partners raised its holdings in Humana by 435.8% in the 4th quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock valued at $279,236,000 after acquiring an additional 893,637 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on HUM. Oppenheimer raised their price objective on shares of Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a report on Thursday, May 1st. Mizuho boosted their price target on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Barclays set a $268.00 price objective on Humana and gave the stock an "equal weight" rating in a research note on Thursday, June 12th. Guggenheim started coverage on shares of Humana in a report on Wednesday, April 9th. They issued a "buy" rating and a $326.00 target price on the stock. Finally, Wall Street Zen upgraded shares of Humana from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Sixteen analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to data from MarketBeat, Humana has a consensus rating of "Hold" and a consensus price target of $280.76.

Humana Stock Down 1.1%

Shares of Humana stock traded down $2.68 during trading hours on Monday, reaching $237.00. 1,367,126 shares of the company's stock were exchanged, compared to its average volume of 1,815,961. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.71. The company has a 50 day moving average of $240.29 and a two-hundred day moving average of $259.02. The stock has a market cap of $28.60 billion, a P/E ratio of 16.76, a P/E/G ratio of 1.81 and a beta of 0.44. Humana Inc. has a fifty-two week low of $212.45 and a fifty-two week high of $406.46.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.42% and a return on equity of 14.47%. The business had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. During the same period last year, the business earned $7.23 earnings per share. The firm's revenue was up 8.4% on a year-over-year basis. On average, sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.49%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio is 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.